Synthaverse SA GPW:SVE:
RECEIVES MARKETING AUTHORIZATION FOR ONKO BCG DRUG IN THE NETHERLANDS
On 6ix: 6ix.com/news/synthaverse-receives-marketing-authorization-for-onko-bcg-drug-in-the-netherlands
Synthaverse SA GPW:SVE:
RECEIVES MARKETING AUTHORIZATION FOR ONKO BCG DRUG IN THE NETHERLANDS
SYNTHAVERSE Spolka Akcyjna on 6ix
Follow SYNTHAVERSE Spolka Akcyjna into a list and get an email when it puts out news.
Follow SYNTHAVERSE Spolka Akcyjna